Concepts (59)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Kidney Neoplasms | 2 | 2017 | 103 | 0.600 |
Why?
|
| Ablation Techniques | 1 | 2017 | 13 | 0.520 |
Why?
|
| Cryosurgery | 1 | 2017 | 19 | 0.510 |
Why?
|
| Nephrectomy | 1 | 2017 | 48 | 0.510 |
Why?
|
| Laparoscopy | 1 | 2017 | 159 | 0.450 |
Why?
|
| Remission Induction | 1 | 2017 | 58 | 0.130 |
Why?
|
| Salvage Therapy | 1 | 2017 | 37 | 0.130 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2016 | 7 | 0.130 |
Why?
|
| Fournier Gangrene | 1 | 2016 | 4 | 0.130 |
Why?
|
| Reoperation | 1 | 2017 | 159 | 0.120 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2017 | 79 | 0.120 |
Why?
|
| Cystectomy | 1 | 2017 | 104 | 0.120 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2017 | 81 | 0.120 |
Why?
|
| Length of Stay | 1 | 2016 | 246 | 0.110 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2017 | 166 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2017 | 348 | 0.110 |
Why?
|
| S-Adenosylmethionine | 1 | 2011 | 4 | 0.090 |
Why?
|
| Hepatic Stellate Cells | 1 | 2011 | 23 | 0.090 |
Why?
|
| Collagen Type I | 1 | 2011 | 27 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2017 | 2430 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2011 | 109 | 0.080 |
Why?
|
| Antioxidants | 1 | 2011 | 225 | 0.070 |
Why?
|
| Humans | 4 | 2017 | 29078 | 0.070 |
Why?
|
| Time Factors | 2 | 2017 | 1619 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2017 | 2651 | 0.040 |
Why?
|
| American Cancer Society | 1 | 2017 | 4 | 0.030 |
Why?
|
| Medicaid | 1 | 2017 | 55 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2017 | 93 | 0.030 |
Why?
|
| Aged | 2 | 2017 | 5627 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2017 | 211 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2017 | 303 | 0.030 |
Why?
|
| Robotic Surgical Procedures | 1 | 2017 | 54 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2017 | 271 | 0.030 |
Why?
|
| Male | 3 | 2017 | 14049 | 0.030 |
Why?
|
| Prognosis | 1 | 2016 | 815 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 2070 | 0.020 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2011 | 6 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2011 | 44 | 0.020 |
Why?
|
| Ubiquitination | 1 | 2011 | 33 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2011 | 38 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2011 | 80 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2011 | 80 | 0.020 |
Why?
|
| United States | 1 | 2017 | 2252 | 0.020 |
Why?
|
| Protein Transport | 1 | 2011 | 158 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2011 | 202 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 393 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2011 | 191 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2011 | 247 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2011 | 554 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 612 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2011 | 405 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2011 | 668 | 0.020 |
Why?
|
| Rats | 1 | 2011 | 1594 | 0.020 |
Why?
|
| Middle Aged | 1 | 2016 | 7458 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2011 | 1482 | 0.010 |
Why?
|
| Adult | 1 | 2016 | 8080 | 0.010 |
Why?
|
| Mice | 1 | 2011 | 4845 | 0.010 |
Why?
|
| Female | 1 | 2017 | 15740 | 0.010 |
Why?
|
| Animals | 1 | 2011 | 10756 | 0.010 |
Why?
|